Bictegravir/emtricitabine/tenofovir-alafenamide/cobicistat/darunavir/emtricitabine/tenofovir-alafenamideHyperglycaemia and gastrointestinal side effects: case report

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2024年 / 2039卷 / 1期
关键词：
D O I：
10.1007/s40278-024-72544-y
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：107 / 107
相关论文
共 50 条
  • [41] Optic Neuritis due to Use of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide: A Case Report
    Acar, Turkan
    Eryilmaz, Halil Alper
    Atilgan Acar, Bilgehan
    Guclu, Ertugrul
    Karabay, Oguz
    NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY, 2022, 59 (01): : 80 - 82
  • [42] Bictegravir/emtricitabine/tenofovir-alafenamideHyperbilirubinaemia: case report
    Reactions Weekly, 2023, 1944 (1) : 158 - 158
  • [43] Bictegravir/emtricitabine/tenofovir-alafenamideHypokalaemia: case report
    Reactions Weekly, 2023, 1941 (1) : 108 - 108
  • [44] Bictegravir/emtricitabine/tenofovir alafenamideVirologic failure: case report
    Reactions Weekly, 2020, 1826 (1) : 82 - 82
  • [45] Bictegravir/emtricitabine/tenofovir-alafenamidePancolitis: case report
    Reactions Weekly, 2025, 2054 (1) : 94 - 94
  • [46] Body mass index increase and weight gain among people living with HIV-1 initiated on single-tablet darunavir/cobicistat/emtricitabine/tenofovir alafenamide or bictegravir/emtricitabine/tenofovir alafenamide in the United States
    Emond, Bruno
    Rossi, Carmine
    Cote-Sergent, Aurelie
    Bookhart, Brahim
    Anderson, David
    Lefebvre, Patrick
    Lafeuille, Marie-Helene
    Donga, Prina
    CURRENT MEDICAL RESEARCH AND OPINION, 2022, 38 (02) : 287 - 298
  • [47] Darunavir-cobicistat-emtricitabine-tenofovir alafenamide: safety and efficacy of a protease inhibitor in the modern era
    Squillace, Nicola
    Bozzi, Giorgio
    Colella, Elisa
    Gori, Andrea
    Bandera, Alessandra
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2018, 12 : 3635 - 3643
  • [48] Emtricitabine/tenofovir alafenamide/emtricitabine/tenofovir disoproxil fumarateHypophosphataemia secondary to proximal tubular dysfunction: case report
    Reactions Weekly, 2021, 1874 (1) : 104 - 104
  • [49] The safety and efficacy of the use of Biktarvy (bictegravir, emtricitabine and tenofovir alafenamide) with boosted darunavir in clinical practice
    Tyler, Stephanie
    Collins, Nadine
    Barchi, Will
    Kulasegaram, Ranjababu
    HIV MEDICINE, 2022, 23 : 32 - 32
  • [50] Real-life safety of Emtricitabine/Tenofovir Alafenamide/Bictegravir
    Squillace, Nicola
    Ricci, Elena
    Maggi, Paolo
    Taramasso, Lucia
    Menzaghi, Barbara
    De Socio, Giuseppe Vittorio
    Piconi, Stefania
    Maurizio Celesia, Benedetto
    Orofino, Giancarlo
    Sarchi, Eleonora
    Pellicano, Giovanni Francesco
    Simeone, Filomena
    Valsecchi, Laura
    Bandera, Alessandra
    Cenderello, Giovanni
    Attala, Letizia
    Angioni, Goffredo
    Falasca, Katia
    Cascio, Antonio
    Bargiacchi, Olivia
    Di Biagio, Antonio
    Bonfanti, Paolo
    PLOS ONE, 2023, 18 (08):
12345